2 minute read
Research news
Geisinger’s Cancer Institute awarded Gold Certificate of Excellence
Geisinger’s Cancer Institute recently received a Gold Certificate of Excellence from the National Institutes of Health’s National Cancer Institute (NCI) for its work in increasing enrollment in clinical trials for cancer.
This is the first time Geisinger has received a Gold Certificate from NCI. The award recognizes the team’s work in increasing the number of patients enrolled in clinical trials between August 2023 and July 2024. This award is a testament to the dedication and hard work of the entire team, as well as the trust and participation of our patients.
Promotion
Cora Taylor, PhD, has been named chair of the Department of Developmental Medicine.
Dr. Taylor will oversee a team of clinicians, psychologists, genetic counselors and therapists who care for children with developmental disorders and the department’s research arm, which advances the understanding and treatment of these conditions. We are excited to see Dr. Taylor continue to build Geisinger’s national reputation in caring for children with developmental needs through clinical and research innovation.
New faculty
We were excited to welcome several distinguished faculty members in 2024. Their diverse expertise and innovative ideas will enhance our research capabilities and academic excellence.
• Miranda Hallquist, MS, assistant professor, Department of Genomic Health
• Ana Morales, MS, associate professor, Department of Genomic Health
• Stephanie Kraft, JD, assistant professor, Department of Bioethics & Decision Sciences
• Nick Byrd, PhD, assistant professor, Department of Bioethics & Decision Sciences
• Kate Saylor, PhD, assistant professor, Department of Bioethics & Decision Sciences
Notable research awards
Adam Buchanan, MS, MPH, received a 5-year, $3.7 million grant from the National Institutes of Health for “Making Genomic Medicine Routine in a Rural Healthcare System.” This project will develop genomic medicine resources for diverse healthcare settings, with Geisinger as a clinical site for the Genomic-Enabled Learning Health System (gLHS) Network.
Chris Chabris, PhD, secured a 5-year, $4 million grant from the National Institutes of Health for “PsycheMERGE: Advancing Precision Psychiatry.” This project aims to advance equitable precision psychiatry based on genetics, collaborating with an interdisciplinary team from 11 academic medical centers to address barriers in psychiatric care.
A quick look at how Geisinger Research is turning hypotheses into health.
